114 related articles for article (PubMed ID: 9296087)
1. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.
Lefevre JC; Lepargneur JP; Guion D; Bei S
Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
Lefèvre JC; Lépargneur JP
Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
[TBL] [Abstract][Full Text] [Related]
3. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
Korting HC; Hartinger A
Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
Madhavan HN; Roy S; Malathy J
Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
[TBL] [Abstract][Full Text] [Related]
10. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ofloxacin against Chlamydia trachomatis.
Schachter J; Moncada JV
Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
[TBL] [Abstract][Full Text] [Related]
12. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
15. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
Jones RB; Van der Pol B; Martin DH; Shepard MK
J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
[TBL] [Abstract][Full Text] [Related]
16. In vitro tetracycline susceptibility of Chlamydia trachomatis in clinical specimens.
Hsu AH; Knelsen B; Kasatiya S
Antonie Van Leeuwenhoek; 1987; 53(3):191-6. PubMed ID: 3662489
[TBL] [Abstract][Full Text] [Related]
17. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
Agacfidan A; Moncada J; Schachter J
Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
[TBL] [Abstract][Full Text] [Related]
19. Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.
Rupp J; Solbach W; Gieffers J
J Antimicrob Chemother; 2008 Jan; 61(1):91-4. PubMed ID: 18033786
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN
Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
